Alteplase for treatment of acute ischaemic stroke: independent review
皇冠体育app review of alteplase in the treatment of acute ischaemic stroke by the expert working group of the Commission on Human Medicines.
Documents
Details
皇冠体育app Commission on Human Medicines (CHM) has fully endorsed the conclusions and recommendations of the expert working group on alteplase in the treatment of stroke, confirming that the benefit of alteplase outweighs the risk when used up to 4.5 hours after symptoms appear.
皇冠体育app commission supported full transparency and the publication of all information considered by the group. Some information has been redacted to protect the identity of individuals and details of unpublished data.
皇冠体育app group considered the data above to reach their conclusions.
See the for more details on alteplase.